Objectives

After participating in this educational activity, attendees should be able to:
1. Recognize aspects of treatment that increase risk of late effects.
2. Discuss the risk of complications.
3. Describe specific chronic medical conditions associated with childhood cancer treatment.
4. Identify resources for screening recommendations.

Faculty

Kenneth Bujold, DO, MS
Assistant Professor
Pediatric Hematology/Oncology
Baystate Children's Hospital
UMASS Chan Medical School - Baystate
 

Faculty Disclosure

The design and content of Baystate Continuing Interprofessional Education (CE) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options. Any relevant financial relationships are mitigated prior to the educational activity.

None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. 

Accreditation Statement
In support of improving patient care, Baystate Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Physicians
Baystate Continuing Interprofessional Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)^TM.  Physicians should only claim the credit commensurate with the extent of their participation in the activity.

Nurses
Baystate Continuing Interprofessional Education designates this live activity for a maximum of 1.0 contact hour(s).  Nurses should only claim the credit commensurate with the extent of their participation in the activity.

This activity was planned by and for the healthcare team and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.